Literature DB >> 35947873

Quantification of left atrial fibrosis by 3D late gadolinium-enhanced cardiac magnetic resonance imaging in patients with atrial fibrillation: impact of different analysis methods.

Luuk H G A Hopman1, Pranav Bhagirath1, Mark J Mulder1, Iris N Eggink1, Albert C van Rossum1, Cornelis P Allaart1, Marco J W Götte1.   

Abstract

AIMS: Various methods and post-processing software packages have been developed to quantify left atrial (LA) fibrosis using 3D late gadolinium-enhancement cardiac magnetic resonance (LGE-CMR) images. Currently, it remains unclear how the results of these methods and software packages interrelate. METHODS AND
RESULTS: Forty-seven atrial fibrillation (AF) patients underwent 3D-LGE-CMR imaging prior to their AF ablation. LA fibrotic burden was derived from the images using open-source CEMRG software and commercially available ADAS 3D-LA software. Both packages were used to calculate fibrosis based on the image intensity ratio (IIR)-method. Additionally, CEMRG was used to quantify LA fibrosis using three standard deviations (3SD) above the mean blood pool signal intensity. Intraclass correlation coefficients were calculated to compare LA fibrosis quantification methods and different post-processing software outputs. The percentage of LA fibrosis assessed using IIR threshold 1.2 was significantly different from the 3SD-method (29.80 ± 14.15% vs. 8.43 ± 5.42%; P < 0.001). Correlation between the IIR-and SD-method was good (r = 0.85, P < 0.001) although agreement was poor [intraclass correlation coefficient (ICC) = 0.19; P < 0.001]. One-third of the patients were allocated to a different fibrosis category dependent on the used quantification method. Fibrosis assessment using CEMRG and ADAS 3D-LA showed good agreement for the IIR-method (ICC = 0.93; P < 0.001).
CONCLUSIONS: Both, the IIR1.2 and 3SD-method quantify atrial fibrotic burden based on atrial wall signal intensity differences. The discrepancy in the amount of LA fibrosis between these methods may have clinical implications when patients are classified according to their fibrotic burden. There was no difference in results between post-processing software packages to quantify LA fibrosis if an identical quantification method including the threshold was used.
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  atrial fibrillation; atrial fibrosis; atrial remodelling; cardiovascular magnetic resonance (CMR)

Mesh:

Substances:

Year:  2022        PMID: 35947873      PMCID: PMC9365307          DOI: 10.1093/ehjci/jeab245

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   9.130


  22 in total

Review 1.  Use of delayed-enhancement magnetic resonance imaging for fibrosis detection in the atria: a review.

Authors:  Giulia Pontecorboli; Rosa M Figueras I Ventura; Alicia Carlosena; Eva Benito; Susanna Prat-Gonzales; Luigi Padeletti; Lluís Mont
Journal:  Europace       Date:  2017-02-01       Impact factor: 5.214

2.  Atrial remodeling and atrial fibrillation: recent advances and translational perspectives.

Authors:  Stanley Nattel; Masahide Harada
Journal:  J Am Coll Cardiol       Date:  2014-03-19       Impact factor: 24.094

3.  Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Zain Ul Abideen Asad; Ali Yousif; Muhammad Shahzeb Khan; Sana M Al-Khatib; Stavros Stavrakis
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-08-21

4.  Magnetic resonance image intensity ratio, a normalized measure to enable interpatient comparability of left atrial fibrosis.

Authors:  Irfan M Khurram; Roy Beinart; Vadim Zipunnikov; Jane Dewire; Hirad Yarmohammadi; Takeshi Sasaki; David D Spragg; Joseph E Marine; Ronald D Berger; Henry R Halperin; Hugh Calkins; Stefan L Zimmerman; Saman Nazarian
Journal:  Heart Rhythm       Date:  2013-10-03       Impact factor: 6.343

5.  Left Atrial LGE and Arrhythmia Recurrence Following Pulmonary Vein Isolation for Paroxysmal and Persistent AF.

Authors:  Irfan M Khurram; Mohammadali Habibi; Esra Gucuk Ipek; Jonathan Chrispin; Eunice Yang; Kotaro Fukumoto; Jane Dewire; David D Spragg; Joseph E Marine; Ronald D Berger; Hiroshi Ashikaga; Jack Rickard; Yiyi Zhang; Vadim Zipunnikov; Stefan L Zimmerman; Hugh Calkins; Saman Nazarian
Journal:  JACC Cardiovasc Imaging       Date:  2016-01-06

6.  Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.

Authors:  Nassir F Marrouche; David Wilber; Gerhard Hindricks; Pierre Jais; Nazem Akoum; Francis Marchlinski; Eugene Kholmovski; Nathan Burgon; Nan Hu; Lluis Mont; Thomas Deneke; Mattias Duytschaever; Thomas Neumann; Moussa Mansour; Christian Mahnkopf; Bengt Herweg; Emile Daoud; Erik Wissner; Paul Bansmann; Johannes Brachmann
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

Review 7.  Atrial fibrillation and cardiac fibrosis.

Authors:  Christian Sohns; Nassir F Marrouche
Journal:  Eur Heart J       Date:  2020-03-07       Impact factor: 29.983

8.  Verification of threshold for image intensity ratio analyses of late gadolinium enhancement magnetic resonance imaging of left atrial fibrosis in 1.5T scans.

Authors:  Litten Bertelsen; Francisco Alarcón; Laura Andreasen; Eva Benito; Morten Salling Olesen; Niels Vejlstrup; Lluis Mont; Jesper Hastrup Svendsen
Journal:  Int J Cardiovasc Imaging       Date:  2019-11-20       Impact factor: 2.357

9.  Left atrial fibrosis quantification by late gadolinium-enhanced magnetic resonance: a new method to standardize the thresholds for reproducibility.

Authors:  Eva M Benito; Alicia Carlosena-Remirez; Eduard Guasch; Susana Prat-González; Rosario J Perea; Rosa Figueras; Roger Borràs; David Andreu; Elena Arbelo; J Maria Tolosana; Felipe Bisbal; Josep Brugada; Antonio Berruezo; Lluis Mont
Journal:  Europace       Date:  2017-08-01       Impact factor: 5.214

10.  CemrgApp: An interactive medical imaging application with image processing, computer vision, and machine learning toolkits for cardiovascular research.

Authors:  Orod Razeghi; José Alonso Solís-Lemus; Angela W C Lee; Rashed Karim; Cesare Corrado; Caroline H Roney; Adelaide de Vecchi; Steven A Niederer
Journal:  SoftwareX       Date:  2020-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.